Federation des caisses Desjardins du Quebec’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $14.5M | Sell |
|
|||||
|
2025
Q2 | $14.2M | Sell |
|
|||||
|
2025
Q1 | $12.8M | Sell |
|
|||||
|
2024
Q4 | $17.4M | Sell |
|
|||||
|
2024
Q3 | $16.1M | Buy |
|
|||||
|
2024
Q2 | $15.1M | Sell |
|
|||||
|
2024
Q1 | $15.6M | Sell |
|
|||||
|
2023
Q4 | $22.6M | Sell |
|
|||||
|
2023
Q3 | $19.8M | Buy |
|
|||||
|
2023
Q2 | $16.4M | Buy |
|
|||||
|
2023
Q1 | $963K | Buy |
|
|||||
|
2022
Q4 | $156K | Buy |
|
|||||
|
2022
Q3 | $103K | Hold |
|
|||||
|
2022
Q2 | $94.6K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $40.4K | Hold |
|
|||||
|
2020
Q4 | $39.8K | Buy |
|
|||||
|
2020
Q3 | $288 | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $692 | Hold |
|
|||||
|
2019
Q4 | $860 | Hold |
|
|||||
|
2019
Q3 | $721 | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $95.7K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $39.4K | Buy |
|